Futu News, May 5th, announced that this Thursday. $YUNKANG GROUP (02325.HK)$Announcement: The company will conduct a new share offering from May 5th to May 11th, with a planned issuance of 0.138 billion shares, including 13.819 million shares for public offering, and 0.124 billion shares for international offering. The issuing price is 7.89 Hong Kong dollars per share with a minimum board lot of 500 shares, and is expected to be listed on May 18th.
Yun Kang Group is a medical service provider, offering a full range of diagnostic testing services to medical institutions. According to Frost & Sullivan, it held a market share of 3.7% in the Chinese medical service market based on revenue in 2020.
Medical service operations are mainly related to providing diagnostic testing services to medical institutions. These services include diagnostic outsourcing services and diagnostic testing services provided to medical consortiums. The company operates six independent clinical laboratories and on-site diagnostic centers within medical institutions to provide diagnostic testing services, charging diagnostic service fees based on the type and quantity of tests conducted.
As of December 31, 2018, 2019, 2020, and 2021, as well as the latest feasible date, the company has assisted in establishing and operating 79, 132, 199, 275, and 322 on-site diagnostic centers.
According to Frost & Sullivan, in terms of revenue, the company's market share for diagnostic testing services in the medical community market in China in 2020 was 12.5%. Publi...